What is the interpretation of a Forced Vital Capacity (FVC) of 51, a Forced Expiratory Volume in one second to Forced Vital Capacity ratio (FEV1/FVC) of 79.2, and a Forced Expiratory Volume in one second (FEV1) of 64.9?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The pulmonary function test results show a restrictive pattern, with a reduced FVC of 51% of predicted and a normal FEV1/FVC ratio of 79.2%, indicating a significant reduction in lung expansion. The FVC is reduced, indicating a significant reduction in the total amount of air a person can exhale. The FEV1/FVC ratio is normal, which helps distinguish this from obstructive lung disease. The FEV1 is also reduced at 64.9% of predicted. This pattern suggests a restrictive lung disorder, which limits lung expansion. Potential causes include interstitial lung disease, chest wall disorders, neuromuscular weakness, pleural disease, or obesity, as suggested by the European Respiratory Journal study 1.

Key Findings

  • Reduced FVC: 51% of predicted
  • Normal FEV1/FVC ratio: 79.2%
  • Reduced FEV1: 64.9% of predicted
  • Suggests a restrictive lung disorder

Recommendations

  • Further evaluation, including a complete clinical assessment, chest imaging (typically high-resolution CT scan), and possibly additional pulmonary function tests like lung volumes and diffusion capacity, as recommended by the GOLD science committee 1.
  • Treatment would depend on the underlying cause but might include corticosteroids for inflammatory conditions, oxygen therapy if hypoxemia is present, or specific treatments for identified diseases.
  • Pulmonary rehabilitation may also be beneficial to improve exercise capacity and quality of life regardless of the specific diagnosis.

Considerations

  • The use of post-bronchodilator spirometry for the diagnosis of COPD, as recommended by the GOLD science committee 1, is not directly applicable to this case, as the patient's FEV1/FVC ratio is normal.
  • The European Respiratory Journal study 1 provides guidance on the interpretation of lung function tests, including the use of FEV1/VC ratio to diagnose obstructive lung disease.

From the Research

Interpretation of Lung Function Test Results

The given lung function test results are:

  • FVC (Forced Vital Capacity): 51
  • FEV1/FVC (Forced Expiratory Volume in 1 second to Forced Vital Capacity ratio): 79.2
  • FEV1 (Forced Expiratory Volume in 1 second): 64.9

Analysis of Results

  • The FVC result of 51 indicates a severe restrictive lung disease, as the normal range is typically above 80% of the predicted value 2.
  • The FEV1/FVC ratio of 79.2 is within the normal range, indicating that the airway obstruction is not significant 2.
  • The FEV1 result of 64.9 also indicates a severe restrictive lung disease, as the normal range is typically above 80% of the predicted value 2.

Possible Diagnosis

Based on the results, the possible diagnosis is a restrictive lung disease, such as idiopathic pulmonary fibrosis (IPF) 3, 4, 5, 6. IPF is a chronic, progressive form of interstitial lung disease characterized by fibrosis and worsening lung function.

Key Characteristics of IPF

  • IPF is a severe and currently incurable disease that is associated with irreversible fibrotic remodeling of the lung parenchyma 3.
  • The disease is characterized by a reduction in the diffusing capacity of the lungs for respiratory gases and changes in the mechanical properties of lung tissue 3.
  • IPF can only be slowed pharmacologically, not reversed, and early detection and treatment are crucial to slow disease progression and improve quality of life 3, 4, 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis.

European respiratory review : an official journal of the European Respiratory Society, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.